Mark A Kay Logic Bio Therapeutics, Inc. (LOGC) insider trading activity

LOGC Quotes by TradingView

Mark A Kay is Director of LogicBio Therapeutics, Inc.. Currently has a direct ownership of 0 shares of LOGC, which is worth approximately $0. The most recent transaction as insider was on Nov 16, 2022, when has been sold 784,557 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mark A Kay Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2022
SELL
Sale (or disposition) back to the issuer
-
784,557 Reduced 100.0%
0 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
2,199 Added 50.0%
2,199 Common Stock
MAK

Mark A Kay

Director
Lexington, MA

Track Institutional and Insider Activities on LOGC

Follow LogicBio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LOGC shares.

Notify only if

Insider Trading

Get notified when an Logic Bio Therapeutics, Inc. insider buys or sells LOGC shares.

Notify only if

News

Receive news related to LogicBio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LOGC